The drug targets the overgrowth of synovial cells and inflammatory components that drive tumor development and joint ...

Deciphera Pharmaceuticals, LLC, a biopharmaceutical company focused on discovering, developing, and commercializing important ...

ASCO 2025 showcased breakthroughs in sarcoma treatment, emphasizing precision medicine, immunotherapy, and promising new ...

The researchers used genetically engineered mouse models, human colon cancer cell lines, and organoid cultures to analyze how deletion or overexpression of CDX1/2 affected tumor behavior.

NEW YORK – Researchers in Australia are hopeful that a new CRISPR-edited CAR T-cell therapy candidate for solid tumors, including breast and ovarian cancers, could better deliver immune-stimulating ...

TURALIO Ⓡ (pexidartinib) is indicated for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) associated with severe morbidity or functional limitations and not ...